Bank of Montreal
LAB icon

Bank of Montreal’s Standard BioTools LAB Stock Holding History

Bank of Montreal’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-41,903
Closed -$74.2K – 4071
2024
Q2 		$74.2K Buy
+41,903
New +$102K ﹤0.01% 3334
2021
Q2 		– Sell
-4,089
Closed -$19K – 4343
2021
Q1 		$19K Sell
4,089
-8,481
-67% -$46.6K ﹤0.01% 4083
2020
Q4 		$79K Buy
12,570
+8,306
+195% +$54.6K ﹤0.01% 3705
2020
Q3 		$37K Sell
4,264
-1,367
-24% -$9.44K ﹤0.01% 3558
2020
Q2 		$31K Buy
+5,631
New +$19.6K ﹤0.01% 3651
2020
Q1 		– Sell
-8,780
Closed -$31K – 4406
2019
Q4 		$31K Sell
8,780
-7,002
-44% -$24.6K ﹤0.01% 4059
2019
Q3 		$73K Sell
15,782
-427
-3% -$3.36K ﹤0.01% 3450
2019
Q2 		$199K Buy
+16,209
New +$206K ﹤0.01% 2922
2019
Q1 		– Sell
-347
Closed -$3K – 4536
2018
Q4 		$3K Buy
347
+169
+95% +$1.32K ﹤0.01% 4259
2018
Q3 		$1K Sell
178
-4
-2% -$28 ﹤0.01% 4552
2018
Q2 		$1K Buy
+182
New +$1.04K ﹤0.01% 4545
2017
Q2 		– Sell
-139
Closed -$1K – 4218
2017
Q1 		$1K Hold
139
– – ﹤0.01% 3890
2016
Q4 		$1K Hold
139
– – ﹤0.01% 3968
2016
Q3 		$1K Buy
+139
New +$1.28K ﹤0.01% 3936
2016
Q2 		– Sell
-109
Closed -$1K – 4215
2016
Q1 		$1K Sell
109
-335
-75% -$2.42K ﹤0.01% 4074
2015
Q4 		$5K Buy
+444
New +$4.36K ﹤0.01% 3790
2015
Q1 		– Sell
-10,149
Closed -$342K – 4097
2014
Q4 		$342K Buy
10,149
+3,282
+48% +$92.9K ﹤0.01% 2240
2014
Q3 		$168K Buy
6,867
+6,157
+867% +$173K ﹤0.01% 2607
2014
Q2 		$21K Buy
+710
New +$22.8K ﹤0.01% 3562
2013
Q4 		– Sell
-8,680
Closed -$190K – 3830
2013
Q3 		$190K Hold
8,680
– – ﹤0.01% 2266
2013
Q2 		$152K Buy
+8,680
New +$152K ﹤0.01% 2292

Other funds holding LAB

CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of Montreal's LAB Position: Q3 2024 in Review

Bank of Montreal sold out of Standard BioTools (LAB) in Q3 2024, closing a stake of 41,903 shares — an estimated $74.2K sold.

Bank of Montreal first reported a position in LAB in Q2 2013 and held it in 21 quarters. The position peaked at $342K in Q4 2014. 141 funds tracked by Wall St. Rank hold LAB as of Q3 2024.

  • Bank of Montreal reported no remaining Standard BioTools position as of Q3 2024 after selling out during the quarter.
  • Bank of Montreal sold 41,903 Standard BioTools shares in Q3 2024, an estimated $74.2K.
  • Bank of Montreal first reported a position in Standard BioTools in Q2 2013 and held it in 21 quarters.
  • Bank of Montreal's Standard BioTools position peaked at $342K in Q4 2014.
  • 141 funds tracked by Wall St. Rank held Standard BioTools as of Q3 2024.

Based on Bank of Montreal's 13F filing for Q3 2024, filed 13 Nov 2024.